Matador Mining Ltd (ASX:MZZ, OTCQX:MZZMF) welcomes the private, non-brokered A$3.6 million strategic investment by Canadian-based global gold miner B2Gold Corp to step-up exploration at the Malachite prospect in Newfoundland, Canada.
B2Gold will subscribe for 31,010,290 shares at A$0.1162 each for gross proceeds of A$3,602,682. This will give B2Gold a 9.9% stake in Matador.
European Lithium Ltd (ASX:EUR, OTCQB:EULIF)’s flagship Wolfberg Lithium Project is set to list on the Nasdaq under the Critical Metals Corp banner, following a binding agreement with special purpose acquisition company (SPAC) Sizzle Acquisitions Corp.
A SPAC or ‘blank check company’, has no commercial operations, but becomes a public company and then acquires, or usually merges with, an existing company, taking it public.
Atlantic Lithium Limited (AIM:ALL, OTCQX:ALLIF, ASX:A11) has garnered a repeat 'buy' rating with a 46p price target from analysts at Liberum Capital who noted that the company's "best-in-class Ewoyaa spodumene lithium project in Ghana continues to deliver".
The 'house' broker's analysts pointed out that the latest assay results, reported by the company last Thursday, provided further confidence both in resource conversion and in extending mineralisation.
BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) has highlighted the unique composition of one of its Bio CELLicitation-based cannabis products grown from a CBD Hemp plant that the company said has major medical and commercial implications.
The company said the analysis of its composition was derived using industry-standard HPLC measurements conducted by an independent third-party analytical laboratory which is ISO17025 cGMP accredited and certified by the Israeli Ministry of Health.
Argentina Lithium & Energy Corp (TSX-V:LIT, OTCQB:PNXLF) has announced positive lithium brine values from the third and fourth diamond drill holes at its Rincon West project in Salta Province, Argentina.
A fifth exploration hole is currently in the final stages of completion, the company said.
Nextech AR Solutions Corp. (CSE:NTAR, OTCQB:NEXCF) has announced that the spatial computing technology of its spin-off ARway (CSE:ARWY) is now being used as part of the XR engine powering Encore, a live interactive music app co-founded by rapper Kid Cudi.
This application of the ARway platform opens up a “substantial new market”, providing augmented reality (AR) spatial activations for the music industry, Nextech said.
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) said it has signed a deal worth up to US$208mln in upfront and milestone payments to license its anti-glycan antibody to cancer therapy specialist Genmab (CSE:GEN).
A US$24bn Nasdaq-listed Danish group, Genmab has been granted an exclusive worldwide licence to develop and commercialise the antibody for all therapeutic and disease areas barring cell therapies.
Pantheon Resources PLC (AIM:PANR, OTC:PTHRF) told investors that the Alkaid-2 well in Alaska has shown promising indications of reservoir performance whilst it remains in the early phase of clean-up, prior to production testing.
Oil was produced from the well along with a strong flow back of frac fluid – measured in thousands of barrels of fluids per day - including frac sand which was described by Pantheon as higher than expected but not uncommon.
IXICO PLC (AIM:IXI, OTC:PHYOF) said underlying earnings for the year to end-September 2022 are expected to align with market expectations, while its revenue guidance for full-year 2023 remains unchanged from its previously announced forecast of around £7mln.
EBITDA for the 12 months to 30 September 2022 is expected to be £1.5mln, the artificial intelligence data analytics company focused on neuroscience said in a trading update.
Gaming Realms PLC (AIM:GMR, OTCQX:PSDMF) said it has officially launched its content in the US state of Connecticut, with its partner Draftkings Inc (NASDAQ:DKNG).
Five games will go live on the initial launch, with a further nine set to be released shortly, the creator of mobile games said.
Prescient Therapeutics Ltd (ASX:PTX) continues to demonstrate a favourable safety profile with its PTX-100 Phase 1b expansion cohort targeting relapsed and refractory T cell lymphoma (TCL) – and is also delivering on the clinical front.
The study shows that PTX-100 continues to exhibit an excellent safety profile at the highest dose of 2000 mg/m2.
MedX Health Corp. (TSX-V:MDX) has announced that on October 21, 2022, it finalized closing of the private placement of Series III Convertible Loan Notes which, since it was first announced on July 7, 2022., has comprised issuance of a total of 22 Series III Notes, to raise a total of $1.1 million. The Series III Notes, each with a face value of $50,000, bear interest at 8% per year, payable Half-yearly, and will mature on December 31, 2026. They may be converted, at the option of the holder, into units at $0.07 per unit at any time until June 30, 2023, and thereafter at $0.10 until the maturity date. Each Series III unit will be comprised of one fully paid common share and one Series III share purchase warrant. Each warrant will be exercisable to purchase one further common share at the price of $0.07, exercisable for a period expiring on the Series III maturity date. Additionally, the company will have the right to force redemption of any Series III Notes then outstanding, on the date that is thirty days after the date of the notice, exercisable at any time after January 1, 2025, and provided that the company's common shares have closed at a price of $0.30 or above for thirty consecutive trading days immediately preceding the date of the Notice. In connection with the placement of the Series III Notes, the company paid $8,000 in cash commissions. Included among the subscribers was Forest Lane Holdings Limited, a company controlled by David Hennigar, a director of the company, which subscribed for ten Series III Notes, for a total of $500,000. In accordance with relevant regulatory and stock exchange policies, the securities issued in connection with the Series III Notes are restricted from trading for a period of four months from the original issue dates of the Series III Notes.
Victory Square Technologies Inc (CSE:VST, OTCQX:VSQTF) said it has changed its auditor from Dale Matheson Carr-Hilton Labonte, LLP, Chartered Professional Accountant to MNP LLP, Chartered Professional Accountant effective October 13, 2022. The board of directors appointed the successor auditor until the next Annual General Meeting of the company. It said there are no reportable events between the company and the former auditors.
Silver Range Resources Ltd (TSX-V:SNG, OTC:SLRRF) said it has received acceptance from the TSX Venture Exchange for the issuance of 248,465 shares to Paladin Geoscience Corp, a private company controlled by Michael A. Power, Silver Range's president and chief executive officer, under a "Shares for Services Agreement". The shares were issued at deemed prices per share ranging from $0.06125 to $0.109375, being the market prices of Silver Range's shares as traded on the exchange as calculated at the end of each month in which such services were provided, minus 50% of the discount permitted under applicable Exchange Policies, and were issued in partial consideration for geological and other consulting services provided to Silver Range by Paladin during the period April 1, 2022, through September 30, 2022. The shares are subject to a hold period which expires on February 25, 2023.
Wellbeing Digital Sciences (NEO:MEDI.AQN, OTCQB:KONEF) has announced that Najla Guthrie, its CEO, will participate at this years' Wonderland Miami Conference taking place on November 3 to November 5, 2022, at the Mana Wynwood Convention Centre. Guthrie will participate on three panels: November 4 at 9.30am ET- The Politics of Psychedelic Medicine - Will the evidence from psychedelic medicine research move politicians to develop a more rational and progressive drug policy?; November 4 at 5.00pm ET- Building the Last Mile - Building centers of excellence for next generation therapies; and November 5 at 12.20pm ET- Ketamine for Pain & Depression from Randomized Clinical Trials to Real Life Evidence - What does the current data show for using ketamine for pain and depression? The panel will explore how to connect trial results with personalized ketamine treatments. Wonderland is one of the world's largest conferences in the psychedelic medicine sector. Interested parties can register to attend via the following link: https://microdose.buzz/wonderland/
HealthLynked (OTCQB:HLYK) announced it has launched a newly enhanced website design that makes patient navigation more productive. In its ongoing efforts to strengthen, upgrade and build out its HealthLynked Network digital health platform and grow its Health Services Segment, the firm said it has implemented these improvements to provide an easier and more efficient and effective patient experience, something that has been a core objective of HealthLynked from the very beginning. In a statement, CEO Michael Dent told shareholders that consumer demand to help navigate an increasingly complex healthcare system has continued to drive growth in users. “Creating two websites that can focus on both of our markets - patient members and healthcare providers - will improve our messaging and more clearly define our services. Many of the services we provide are bidirectional and the messaging needs to be focused to each specific user group." The current upgrade bifurcates the HealthLynked website into clearer Patient and Provider sites for more clarity and ease of use for both constituents. Visit HealthLynked Network's Patient Portal at https://www.healthlynked.com/ and the Provider site at https://provider.healthlynked.com.
Bridgeline Digital Inc (NASDAQ:BLIN) announced today its partnership with the world's largest Optimizely agency, Niteco, which services 500 customers in 30 countries including Panasonic, Heineken, and Electrolux. This partnership presents significant revenue-generating opportunities by combining Bridgeline's site search software Hawksearch, with the expertise offered by Niteco's 350 Optimizely experts, according to the company. Hawksearch is Optimizely's first non-native site search and is integrated with Optimizely's B2B and B2C platforms. It currently powers the search for Optimizely customers such as Crescent Electric, Winston Brands, and Cleaner's Supply. "Bridgeline is excited to join forces with a top-tier Optimizely partner," said Ari Kahn, CEO of Bridgeline in a statement. "We look forward to working with Niteco to generate revenue for our customers."
Chesapeake Financial Shares Inc, the parent company of Chesapeake Bank and Chesapeake Wealth Management, said that its board of directors have approved a dividend of US$0.150 per share to shareholders of record as of December 1 this year, payable on or before December 15, 2022.
G2 Energy Corp clarified in an announcement Tuesday that the units offered in its $1 million non-brokered convertible debenture private placement last week have a maturity date of 24 months, which was misstated in a previous statement. Proceeds from the financing will be primarily used to finance the company’s six-month plan to close its acquisition of Bridwell Oil Company’s Masten lease in Texas ($230,000) and conduct associated oil well work (around US$700,000).
MAS Gold Corp announced that, subject to the approval of the TSX Venture Exchange, it intends to reprice 17,077,881 share purchase warrants originally issued by the company on December 30, 2020, pursuant to a non-brokered private placement. The warrants were exercisable into company common shares at a price of $0.10 per common share and currently have an expiry date of December 30, 2022. MAS Gold noted it wishes to reprice the warrants to $0.045 effective the date of TSX Exchange approval. All other terms of the warrants, including expiry date, will remain the same.
Great Atlantic Resources Corp announced that it has arranged a non-brokered private placement offering of up to 5 million company units, at a price of C$0.035 per unit, for gross proceeds of up to C$175,000. The Canadian exploration company said it intends to use the net proceeds from the offering for exploration at its Golden Promise Gold property in Newfoundland as well as general working capital as well as exploration work on its other assets located in Newfoundland and New Brunswick. Each unit will consist of one company common share plus one common share purchase warrant, with each warrant will be exercisable to purchase one Great Atlantic common share at an exercise price of $0.05 per warrant share for a period of 60 months following the closing of the offering. A finder's fee may be paid to eligible finders in accordance with the TSX Venture exchange policies. All securities issued pursuant to the offering will be subject to a hold period of four months and one day from the date of closing.
Westwater Resources Inc announced that it will hold a conference call on November 10, 2022, at 11AM EDT to discuss its financial results for the third quarter that ended September 30, 2022, and will update investors as to progress at its Kellyton graphite plant. Hosting the call will be Westwater CEO Chad Potter, who will be joined by the company’s executive chairman Terence Cryan, and by Steven Cates, Westwater’s chief financial officer and vice president-finance. Potter will present an update on construction and recent events at the Kellyton graphite processing plant, while Cates will review the financial results and the company's financial condition. Management will be available for questions as part of the call. Dial-In-Numbers: 1-800-319-4610 (USA and Canada); 1-604-638-5340 (International); Conference ID: Westwater Resources Conference Call.